10-Q Filing

ACCELERATE DIAGNOSTICS, INC CIK: 727207 Q1 2012

Filing Information

Form Type	10-Q
Accession Number	`0001000096-12-000189`
Period End Date	20121031
Filing Date	20121214
Fiscal Year	2012
Fiscal Period	Q1
XBRL Instance	axk-20121031.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 38 Cash Flow Statement 52

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Common Stock, no par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, no par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	45.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	45.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	11.10M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.26M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	25.33M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$584.99K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	25.33M	shares	Point-in-time
Trade accounts receivable	`ReceivablesNetCurrent`	$753.20K	USD	Point-in-time
Trade accounts receivable	`ReceivablesNetCurrent`	$750.95K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	11.10M	shares	Point-in-time
Shares held for employee benefit	`DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital`	$1.13M	USD	Point-in-time
Inventory	`InventoryNet`	$10.26K	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Shares held for employee benefit	`DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital`	$1.13M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$19.44K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$17.93K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.97M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.04M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.96K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$73.33K	USD	Point-in-time
Investments, net	`Goodwill`	$1.49M	USD	Point-in-time
Investments, net	`Goodwill`	$1.50M	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$325.36K	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$680.94K	USD	Point-in-time
Total Assets	`Assets`	$15.86M	USD	Point-in-time
Total Assets	`Assets`	$17.21M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$83.91K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$63.03K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$1.24M	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$1.27M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$85.34K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$82.81K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.44M	USD	Point-in-time
Deferred compensation	`DeferredCompensationLiabilityCurrent`	$986.46K	USD	Point-in-time
Deferred compensation	`DeferredCompensationLiabilityCurrent`	$986.46K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.38M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.43M	USD	Point-in-time
Common stock, no par value; 45,000,000 shares authorized; 25,331,939 shares (October 31, 2012) and11,103,367 shares (July 31, 2012) issued and outstanding	`CommonStockNoParValue`	$23.09M	USD	Point-in-time
Common stock, no par value; 45,000,000 shares authorized; 25,331,939 shares (October 31, 2012) and11,103,367 shares (July 31, 2012) issued and outstanding	`CommonStockNoParValue`	$22.99M	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$8.09M	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$7.92M	USD	Point-in-time
Accumulated deficit	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-17.47M	USD	Point-in-time
Accumulated deficit	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.80M	USD	Point-in-time
Shares held for employee benefit (1,129,110 shares at cost)	`SharesHeldInEmployeeStockOptionPlanAllocated`	-273,600.00	shares	Point-in-time
Shares held for employee benefit (1,129,110 shares at cost)	`SharesHeldInEmployeeStockOptionPlanAllocated`	-273,600.00	shares	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$13.44M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$14.84M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$17.21M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$15.86M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Technical development fees	`ProfessionalAndContractServicesExpense`	$-140.00K	USD	1 Quarter
Technical development fees	`ProfessionalAndContractServicesExpense`	-	USD	1 Quarter
OptiChem revenue	`LicensesRevenue`	$12.01K	USD	1 Quarter
OptiChem revenue	`LicensesRevenue`	$2.53K	USD	1 Quarter
License fees	`CostOfServicesLicensesAndServices`	-	USD	1 Quarter
License fees	`CostOfServicesLicensesAndServices`	$-50.00K	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	-	USD	1 Quarter
Grant revenue	`RevenueFromGrants`	$5.78K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$8.30K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$202.01K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$104.16K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$564.22K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$754.10K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$458.98K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$25.33K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$64.09K	USD	1 Quarter
Marketing and sales	`SellingAndMarketingExpense`	$6.12K	USD	1 Quarter
Marketing and sales	`SellingAndMarketingExpense`	$4.17K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$1.81K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$515.00	USD	1 Quarter
Other expense, impairment of intangibles	`OtherExpenses`	$333.49K	USD	1 Quarter
Other expense, impairment of intangibles	`OtherExpenses`	-	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$1.69M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$631.92K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.68M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-429.91K	USD	1 Quarter
Interest and dividend income	`OtherNonoperatingIncome`	$1.15K	USD	1 Quarter
Interest and dividend income	`OtherNonoperatingIncome`	$4.00K	USD	1 Quarter
Unrealized holding gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$-4.37K	USD	1 Quarter
Unrealized holding gain (loss) on investments	`UnrealizedGainLossOnInvestments`	$10.56K	USD	1 Quarter
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-365.00	USD	1 Quarter
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$11.70K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-430.27K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.67M	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	25.26M	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	11.10M	shares	1 Quarter

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-430.27K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.67M	USD	1 Quarter
Depreciation	`Depreciation`	$515.00	USD	1 Quarter
Depreciation	`Depreciation`	$1.81K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$25.33K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$64.09K	USD	1 Quarter
Fair value of stock options granted for services	`ShareBasedCompensation`	$272.53K	USD	1 Quarter
Fair value of stock options granted for services	`ShareBasedCompensation`	$168.52K	USD	1 Quarter
Unrealized holding (gain) loss on investments	`GainLossOnInvestments`	$-10.56K	USD	1 Quarter
Unrealized holding (gain) loss on investments	`GainLossOnInvestments`	$4.37K	USD	1 Quarter
Realized (gain) loss on investments, interest and dividends reinvested	`OtherNoncashExpense`	$-1.15K	USD	1 Quarter
Realized (gain) loss on investments, interest and dividends reinvested	`OtherNoncashExpense`	-	USD	1 Quarter
Other expense, impairment loss	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	$333.49K	USD	1 Quarter
Other expense, impairment loss	`ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.26K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-165.75K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$10.26K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	-	USD	1 Quarter
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$9.83K	USD	1 Quarter
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.51K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$21.73K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$20.88K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$11.50K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$28.60K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$95.48K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-2.53K	USD	1 Quarter
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	$16.32K	USD	1 Quarter
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	-	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-99.67K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.09M	USD	1 Quarter
Purchase investments	`FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnobservableInputInvestmentHoldingsMovementsNet`	$-1.94K	USD	1 Quarter
Purchase investments	`FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnobservableInputInvestmentHoldingsMovementsNet`	-	USD	1 Quarter
Purchases of equipment and patent costs	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.26K	USD	1 Quarter
Purchases of equipment and patent costs	`PaymentsToAcquirePropertyPlantAndEquipment`	$73.27K	USD	1 Quarter
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$-75.00K	USD	1 Quarter
Contribution to deferred compensation trust	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-73.27K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-91.20K	USD	1 Quarter
Exercise of warrants and options	`ProceedsFromStockOptionsExercised`	$128.57K	USD	1 Quarter
Exercise of warrants and options	`ProceedsFromStockOptionsExercised`	$100.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$128.57K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$100.00K	USD	1 Quarter
Decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-190.87K	USD	1 Quarter
Decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.07M	USD	1 Quarter
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$14.26M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$13.20M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$584.99K	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$14.26M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$13.20M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$775.86K	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$584.99K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.